HUP0000073A3 - Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase - Google Patents

Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase

Info

Publication number
HUP0000073A3
HUP0000073A3 HU0000073A HUP0000073A HUP0000073A3 HU P0000073 A3 HUP0000073 A3 HU P0000073A3 HU 0000073 A HU0000073 A HU 0000073A HU P0000073 A HUP0000073 A HU P0000073A HU P0000073 A3 HUP0000073 A3 HU P0000073A3
Authority
HU
Hungary
Prior art keywords
farnesyl
inhibitors
useful
protein transferase
benzocycloheptapyridine
Prior art date
Application number
HU0000073A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of HUP0000073A2 publication Critical patent/HUP0000073A2/hu
Publication of HUP0000073A3 publication Critical patent/HUP0000073A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pyridine Compounds (AREA)
HU0000073A 1996-09-13 1997-09-11 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase HUP0000073A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71370596A 1996-09-13 1996-09-13
PCT/US1997/015902 WO1998011097A1 (en) 1996-09-13 1997-09-11 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase

Publications (2)

Publication Number Publication Date
HUP0000073A2 HUP0000073A2 (hu) 2001-10-28
HUP0000073A3 true HUP0000073A3 (en) 2002-02-28

Family

ID=24867191

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0000073A HUP0000073A3 (en) 1996-09-13 1997-09-11 Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase

Country Status (13)

Country Link
EP (1) EP0931077B1 (https=)
JP (1) JP2001500506A (https=)
KR (1) KR20000036102A (https=)
CN (1) CN1104428C (https=)
AT (1) ATE294172T1 (https=)
AU (1) AU4337597A (https=)
CA (1) CA2264666A1 (https=)
DE (1) DE69733142T2 (https=)
ES (1) ES2242232T3 (https=)
HU (1) HUP0000073A3 (https=)
IL (1) IL128926A0 (https=)
NZ (1) NZ334341A (https=)
WO (1) WO1998011097A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2318088A1 (en) 1998-01-21 1999-07-29 Yoshisuke Nakasato Chemokine receptor antagonists and methods of use therefor
AU2331999A (en) 1998-01-21 1999-08-09 Kyowa Hakko Kogyo Co. Ltd. Chemokine receptor antagonists and methods of use therefor
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
WO2005017160A2 (en) 2003-08-13 2005-02-24 Children's Hospital Medical Center Mobilization of hematopoietic cells
WO2007002254A2 (en) 2005-06-23 2007-01-04 Merck & Co., Inc. Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
CA2657247A1 (en) 2006-07-28 2008-01-31 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
CA2704684A1 (en) 2007-11-07 2009-05-14 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US8178568B2 (en) 2008-07-10 2012-05-15 Boehringer Ingelheim International Gmbh Sulfone compounds which modulate the CB2 receptor
CA2737639A1 (en) 2008-09-25 2010-04-01 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the cb2 receptor
JP5705748B2 (ja) 2009-02-18 2015-04-22 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を変調する複素環化合物
US8299103B2 (en) 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
JP5756800B2 (ja) * 2009-06-16 2015-07-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Cb2受容体を調節するアゼチジン2−カルボキサミド誘導体
WO2011037795A1 (en) 2009-09-22 2011-03-31 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the cb2 receptor
WO2011088015A1 (en) 2010-01-15 2011-07-21 Boehringer Ingelheim International Gmbh Compounds which modulate the cb2 receptor
US8329735B2 (en) 2010-03-05 2012-12-11 Boehringer Ingelheim International Gmbh Tetrazole compounds which selectively modulate the CB2 receptor
WO2012012307A1 (en) 2010-07-22 2012-01-26 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the cb2 rece
EP2803668A1 (en) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1593417A (en) * 1976-12-22 1981-07-15 Squibb & Sons Inc Carbocyclic-fused pyrazolopyridine derivatives
US5089496A (en) * 1986-10-31 1992-02-18 Schering Corporation Benzo[5,6]cycloheptapyridine compounds, compositions and method of treating allergies
IE68935B1 (en) * 1990-06-22 1996-07-24 Schering Corp Bis-benzo or benzopyrido cyclohepta piperidene piperidylidene and piperazine compounds compositions and methods of use
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
CA2174105C (en) * 1993-10-15 2002-02-12 W. Robert Bishop Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
NZ334341A (en) 2001-01-26
JP2001500506A (ja) 2001-01-16
HUP0000073A2 (hu) 2001-10-28
DE69733142D1 (de) 2005-06-02
EP0931077A1 (en) 1999-07-28
CN1104428C (zh) 2003-04-02
DE69733142T2 (de) 2006-03-16
ATE294172T1 (de) 2005-05-15
KR20000036102A (ko) 2000-06-26
EP0931077B1 (en) 2005-04-27
CN1236365A (zh) 1999-11-24
ES2242232T3 (es) 2005-11-01
AU4337597A (en) 1998-04-02
IL128926A0 (en) 2000-02-17
WO1998011097A1 (en) 1998-03-19
CA2264666A1 (en) 1998-03-19

Similar Documents

Publication Publication Date Title
GB9604311D0 (en) Inhibitors of farnesyl-protein transferase
AU1844497A (en) Inhibitors of farnesyl-protein transferase
AU2253097A (en) Inhibitors of farnesyl-protein transferase
HUP0000073A3 (en) Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase
AU2430197A (en) Inhibitors of farnesyl-protein transferase
EP1045844A4 (en) INHIBITORS OF FARNESYL PROTEIN TRANSFERASE
AU1851697A (en) Inhibitors of farnesyl-protein transferase
AU2432597A (en) Inhibitors of farnesyl-protein transferase
AU2432697A (en) Inhibitors of farnesyl-protein transferase
AU2430397A (en) Inhibitors of farnesyl-protein transferase
AU1952697A (en) Inhibitors of farnesyl-protein transferase
GB9721000D0 (en) Inhibitors of farnesyl-protein transferase
HK1018444A (en) Substituted benzocycloheptapyridine useful as inhibitors of farnesyl-protein transferase
GB9617257D0 (en) Inhibitors of farnesyl-protein transferase
GB9610654D0 (en) Inhibitors of farnesyl-protein transferase
GB9613461D0 (en) Inhibitors of farnesyl-protein transferase
GB9613462D0 (en) Inhibitors of farnesyl-protein transferase
GB9613600D0 (en) Inhibitors of farnesyl-protein transferase
GB9613690D0 (en) Inhibitors of farnesyl-protein transferase
GB9614315D0 (en) Inhibitors of farnesyl-protein transferase
GB9614316D0 (en) Inhibitors of farnesyl-protein transferase
GB9616736D0 (en) Inhibitors of farnesyl-protein transferase
GB9617254D0 (en) Inhibitors of farnesyl-protein transferase
GB9617255D0 (en) Inhibitors of farnesyl-protein transferase
GB9612291D0 (en) Inhibitors of farnesyl-protein transferase